Based on the expression of three important BC markers, namely, the progesterone receptor, estrogen receptor, and human epidermal growth factor receptor 2, BC can be categorized into four types: luminal A, luminal B, HER2 (+), and triple-negative breast cancers. Here, ERBB2 is linked to breast cancer.